$58.98 +4.82 (%) Bristol-Myers Squibb Co - NYSE

Oct. 30, 2014 | 04:00 PM

Partner Headlines

  1. Lung cancer drug promising

    IBD | Oct. 30, 2014 | 19:14PM EST
  2. Bristol-Myers Lung-Cancer Drug Boosts Survival

    IBD | Oct. 30, 2014 | 11:31AM EST
  3. #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations

    Benzinga | Oct. 27, 2014 | 08:19AM EST
  4. Eliquis revives Bristol-Myers

    IBD | Oct. 24, 2014 | 18:27PM EST
  5. Bristol-Myers Beats Q3 Views As Eliquis Revives

    IBD | Oct. 24, 2014 | 13:23PM EST
  6. Stocks Flat In Mixed Volume; Amazon.com Weighs On Techs

    IBD | Oct. 24, 2014 | 10:52AM EST
  7. UPDATE: Bristol-Myers Squibb Q3 Earnings Top Estimates

    Benzinga | Oct. 24, 2014 | 08:59AM EST
  8. Stock Futures Aim For Flat Open; Amazon.com Crumples On Q3 Miss

    IBD | Oct. 24, 2014 | 08:58AM EST
  9. #PreMarket Primer: Friday, October 24: Ebola Fears Weigh On Markets

    Benzinga | Oct. 24, 2014 | 07:47AM EST
  10. Earnings Scheduled For October 24, 2014

    Benzinga | Oct. 24, 2014 | 04:51AM EST
  11. Must Watch Stocks for Today

    Benzinga | Oct. 24, 2014 | 04:06AM EST
  12. Stocks Rebound; Amazon.com Slides After Hours

    IBD | Oct. 23, 2014 | 17:02PM EST
  13. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  14. Weekly CFO Sells Highlight: Williams Companies Inc, Google Inc, Bristol-Myers Squibb Company

    GuruFocus | Oct. 19, 2014 | 14:09PM EST
  15. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  16. Apple Leads the Charge as Earnings Season Heats Up

    FoxBusiness | Oct. 17, 2014 | 16:48PM EST
  17. The Six Types of Winning Stocks

    GuruFocus | Oct. 17, 2014 | 14:38PM EST
  18. Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level

    Benzinga | Oct. 13, 2014 | 16:57PM EST
  19. Merck to release hep C data

    IBD | Oct. 8, 2014 | 18:38PM EST
  20. Merck, Bristol, Arrowhead Prep Hepatitis Studies

    IBD | Oct. 8, 2014 | 13:36PM EST
  21. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD | Oct. 7, 2014 | 19:33PM EST
  22. Bristol-Myers pulls FDA filing

    IBD | Oct. 7, 2014 | 18:49PM EST
  23. Bristol-Myers Pulls FDA Filing For 2-Drug Hep C Combo

    IBD | Oct. 7, 2014 | 11:13AM EST
  24. Bristol-Myers Squibb Statement About Asunaprevir In The US, WIthdraws NDA

    Benzinga | Oct. 7, 2014 | 08:32AM EST
  25. 2 Mutual Funds Holding Hospital Stocks

    Benzinga | Oct. 6, 2014 | 10:38AM EST
  26. NeurOp Receives Milestone Payment As Bristol-Myers Squibb Nominates NMDA Receptor Compound As Candidate For Drug Development

    Benzinga | Oct. 2, 2014 | 15:16PM EST
  27. Morgan Stanley Believes Bristol-Myers Squibb Co. Could Move Significantly Over Next Several Months

    Benzinga | Oct. 2, 2014 | 10:15AM EST
  28. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD | Sep. 24, 2014 | 17:29PM EST
  29. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  30. Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer Drug

    Benzinga | Sep. 5, 2014 | 16:04PM EST
  31. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  32. Drug M&A Boom Driven By Long-Term Trends: PwC

    IBD | Sep. 3, 2014 | 16:22PM EST
  33. Booming Biotech Market Benefits REIT BioMed Realty

    IBD | Sep. 2, 2014 | 17:42PM EST
  34. Bristol-Myers: Absolute Valuation Model versus Relative Valuation Model

    GuruFocus | Aug. 29, 2014 | 11:04AM EST
  35. Bristol-Myers Drug Gets OK

    IBD | Aug. 27, 2014 | 18:56PM EST
  36. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga | Aug. 27, 2014 | 17:17PM EST
  37. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga | Aug. 27, 2014 | 12:32PM EST
  38. Bristol-Myers Hepatitis C Therapy Approved in EU

    IBD | Aug. 27, 2014 | 12:03PM EST
  39. US Stock Futures Edge Higher Ahead Of Tiffany Earnings

    Benzinga | Aug. 27, 2014 | 07:07AM EST
  40. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD | Aug. 26, 2014 | 12:07PM EST
  41. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD | Aug. 12, 2014 | 10:48AM EST
  42. Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments

    Benzinga | Aug. 11, 2014 | 16:46PM EST
  43. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 17:22PM EST
  44. The Stocks Already in Correction Mode

    FoxBusiness | Aug. 1, 2014 | 08:15AM EST
  45. Will ImmunoGen's Q4 Earnings Disappoint Again?

    GuruFocus | Jul. 30, 2014 | 19:21PM EST
  46. Bristol-Myers surprises Street

    IBD | Jul. 24, 2014 | 18:57PM EST
  47. Thursday Morning Earnings Reports

    Benzinga | Jul. 24, 2014 | 12:14PM EST
  48. Stock Futures Steer Higher; Facebook, Skechers Nail Q2 Wins

    IBD | Jul. 24, 2014 | 09:09AM EST
  49. Earnings Scheduled For July 24, 2014

    Benzinga | Jul. 24, 2014 | 05:31AM EST
  50. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD | Jul. 19, 2014 | 08:02AM EST
Trading Center